Professor of Medicine, Dana-Farber Cancer Institute
Oncology
Dr. Jane C. Weeks, MD
|
|
Give Review
Dr. Jane C. Weeks practices Oncology. She went to Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1 in research and 12 in primary care medicine She received 1 awards: "Fellow (FASCO)". Dr. Jane C. Weeks is a published MD as well. She has 101 publications published. The latest was: Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.
Publications
- Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.
- Catalog and Comparison of Societal Preferences (Utilities) for Lung Cancer Health States: Results from the Cancer Care Outcomes Research and Surveillance (CanCORS) Study.
- The role of families in decisions regarding cancer treatments.
- Symptom prevalence in lung and colorectal cancer patients.
- Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience.
- The relationship between quality, spending and outcomes among women with breast cancer.
- Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
- Did Changes in Drug Reimbursement After the Medicare Modernization Act Affect Chemotherapy Prescribing?
- Invasive procedures in the elderly after stage IV cancer diagnosis.
- Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study.
- Characterization and Treatment of Local Recurrence Following Breast Conservation for Ductal Carcinoma In Situ.
- Advanced Imaging Among Health Maintenance Organization Enrollees With Cancer.
- Physicians' Propensity To Discuss Prognosis Is Associated with Patients' Awareness of Prognosis for Metastatic Cancers.
- Clinical Trial Participation as Part of End-of-Life Cancer Care: Associations With Medical Care and Quality of Life Near Death.
- Treatment of Ductal Carcinoma In Situ After Excision: Would a Prophylactic Paradigm Be More Appropriate?
- Underuse of Hospice Care by Medicaid-Insured Patients With Stage IV Lung Cancer in New York and California.
- Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer.
- Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
- Regional Variation in Spending and Survival for Older Adults With Advanced Cancer.
- Enrollment of patients with lung and colorectal cancers onto clinical trials.
- Chemotherapy use and patient treatment preferences in advanced colorectal cancer: A prospective cohort study.
- Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Co...
- Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.
- Medical oncologists' perceptions of financial incentives in cancer care.
- Palliative Radiation Therapy Practice in Patients With Metastatic Non-Small-Cell Lung Cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
- Time to adjuvant chemotherapy for breast cancer in national comprehensive cancer network institutions.
- Variation in the Utilization of Reconstruction Following Mastectomy in Elderly Women.
- Impact of oncology-related direct-to-consumer advertising: Association with appropriate and inappropriate prescriptions.
- Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
- Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center.
- A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer.
- Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
- Assessing the quality of pain care in ambulatory patients with advanced stage cancer.
- Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
- The Role of National Cancer Institute-Designated Cancer Center Status: Observed Variation in Surgical Care Depends on the Level of Evidence.
- Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopa...
- Re: Personalized Medicine and Cancer Supportive Care: Appropriate Use of Colony-Stimulating Factor Support of Chemotherapy.
- Cost-Effectiveness of Computed Tomography Screening for Lung Cancer in the United States.
- Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.
- Altruism among participants in cancer clinical trials.
- Hospice Care and Survival among Elderly Patients with Lung Cancer.
- Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
- Radiation therapy for ductal carcinoma in situ: A decision analysis.
- Receipt of Appropriate Surgical Care for Medicare Beneficiaries With Cancer.
- Use of Colony-Stimulating Factors With Chemotherapy: Opportunities for Cost Savings and Improved Outcomes.
- Parents' Roles in Decision Making for Children With Cancer in the First Year of Cancer Treatment.
- Long-Term Follow-Up and Individual Item Analysis of Quality of Life Assessments Related to Laparoscopic-Assisted Colectomy in the COST Trial 93-46-53 (INT 0146).
- Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?
- Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost chi...
- Outcomes of informed consent among parents of children in cancer clinical trials.
- Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles?
- Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium.
- The impact of breast reconstruction on the delivery of chemotherapy.
- Employment among survivors of lung cancer and colorectal cancer.
- Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.
- Considerations about hastening death among parents of children who die of cancer.
- End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences.
- The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
- Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer.
- Breast cancer prevention: patient decision making and risk communication in the high risk setting.
- Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.
- Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
- Peace of mind and sense of purpose as core existential issues among parents of children with cancer.
- Discussions with physicians about hospice among patients with metastatic lung cancer.
- Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.
- Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
- Looking beyond where children die: determinants and effects of planning a child's location of death.
- Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.
- Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.
- Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multicenter outcomes ...
- Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.
- Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network.
- Parents' views of cancer-directed therapy for children with no realistic chance for cure.
- Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?
- Selecting high priority quality measures for breast cancer quality improvement.
- American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures.
- Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.
- A qualitative study of oncologists' approaches to end-of-life care.
- Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
- Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction?
- Easing of suffering in children with cancer at the end of life: is care changing?
- Disparities in oncologic surgery.
- Hope and prognostic disclosure.
- Site of oncologic specialty care for older adolescents in Utah.
- Quality of health care for children: role of health and chronic illness in inpatient care experiences.
- Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
- Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients.
- Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction.
- Direct-to-consumer advertising in oncology: a content analysis of print media.
- Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer.
- Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information.
- Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score.
- Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.
- Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women.
- Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information.
- The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
- Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.
- Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers...
- A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.
- The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Dana Farber Canc Institute
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Fellow (FASCO)
Education
-
Brigham and Women's Hospital -
Harvard Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Ramesh A. Shivdasani, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Awad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacy W. Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Levi A. Garraway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole G. Chau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara M. Tolaney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank S. Hodi Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Clark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason S. Fisherman, MD
This Doctor is OpenDoctor Recommended.
|